MedTrace Logo

IMproved PREdiction of Severe Sepsis in the Emergency Department

NCT01392508 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 759

Last updated 2017-04-14

No results posted yet for this study

Summary

The purposes of this study is to determine whether Heparin Binding Protein (HBP) can be used as a marker of severe sepsis (including septic shock) in patients presenting to the emergency department with suspected infection.

Conditions

  • Systemic Inflammatory Response Syndrome (SIRS)
  • Sepsis
  • Severe Sepsis
  • Septic Shock

Sponsors & Collaborators

  • Axis Shield Diagnostics Ltd

    lead INDUSTRY

Principal Investigators

  • Adam Linder · Skanes Universitetssjukhus I Lund, Sweden

  • Magnus Paulsson · Skanes universitetssjukhuset i Malmo

  • Patrik Nyberg · Universitetssjukhuset i Linkoping

  • Anna Lange-Jendeberg · Universitetssjukhuset i Orebro

  • Ryan Arnold · The Cooper Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01392508 on ClinicalTrials.gov